TABLE 2.
Principles of Clinical AI Product Evaluation
| Principles | Questions to be addressed |
|---|---|
| Relevance | What specific medical problem is the AI application intended to solve? Is this intended for research or clinical purposes? Who is the end user? |
| Usability | How will the AI application be integrated into the clinical workflow? How was the model trained? Was the model trained with a well-balanced data set? Was VA data used in model training? Does the AI tool have interpretability? |
| Risk | What are the risks associated with implementation? What are the benefits of clinical adoption? Is there potential for bias? How will potential errors be addressed? |
| Regulatory | Does the AI tool comply with agency and VISN/facility regulations? Is the AI tool compliant with data protection and privacy standards for the VA? How will quality assurance be maintained? |
| Technical requirements | Will the AI tool meet the VA Office of Information and Technology requirements (ie, hardware specifications, cloud vs host, and network security issues)? Who will provide technical oversight and maintenance? |
| Financial | Does the clinical benefit justify cost? What is the licensing model? Is there appropriate sole source justification? What are maintenance costs? |
Abbreviations: AI, artificial intelligence; VA, US Department of Veterans Affairs; VISN, Veterans Integrated Services Network.